Doi.org/10.1179/1973947815Y.0000000053

From WikiComments
Revision as of 05:36, 18 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials; Wang Z, Shang J, Zhang L, Liu P, Xie Y, Zhou Q. ; Journal of Chemotherapy; 2016; https://doi.org/10.1179/1973947815Y.0000000053 == Article providing comments == Comment on: Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials; Sashegyi, Andreas; Zhang,...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Target Article[edit | edit source]

Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials; Wang Z, Shang J, Zhang L, Liu P, Xie Y, Zhou Q. ; Journal of Chemotherapy; 2016; https://doi.org/10.1179/1973947815Y.0000000053

Article providing comments[edit | edit source]

Comment on: Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials; Sashegyi, Andreas; Zhang, Yawei; Lin, Yong; Binder, Polina; Ferry, David; ; Journal of Chemotherapy; 2017-1-2 https://doi.org/10.1080/1120009x.2015.1113023

Summary[edit | edit source]

Note: Opened to append information.

Retrieved from "https://wikicomments.org/index.php?title=Doi.org/10.1179/1973947815Y.0000000053&oldid=1012"